KAYLA SHULL: Open Payments
NPI 1538627468 · KENT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $175 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $149 |
| Alkermes, Inc. | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
Products named: CAPLYTA, ARISTADA, INVEGA SUSTENNA.
Industry payments across WA — which companies pay providers there.
